Ad hoc announcement pursuant to Art. 53 LR
|
|
Ad hoc announcement pursuant to Art. 53 KR
Altstätten, 17 January 2025
COLTENE Holding AG, a leading international developer and manufacturer of dental consumables and small equipment, expects net sales of CHF 250.3 million for the financial year 2024, representing a strong growth compared to 2023. The EBIT margin has also improved considerably compared to the previous year and is expected to reach 10.6%.
According to preliminary figures, COLTENE group sales increased by 3.1% to CHF 250.3 million in the financial year 2024 (2023: CHF 242.7 million). Adjusted for currency effects, this represents a significant growth of 6.3%. Growth was particularly strong in North America, where COLTENE gained market share. Although this was partly achieved on the back of a recovery from the extensive destocking in the previous year, growth was realized despite economic challenges, which had an overall negative impact on the market.
For the financial year 2024, COLTENE expects an EBIT margin of 10.6%, a significant improvement compared to the previous year (8.1%). This increase is primarily due to economies of scale, a strict cost control and the consequent implementation of the Operational Excellence strategy. As part of this strategy, a global procurement organization was introduced that has identified and realized savings opportunities. In addition, a slightly adjusted product mix contributed positively to the operating margin.
COLTENE is maintaining its previously communicated medium-term targets. Management is confident that the defined strategic measures, some of which are already in progress, will further increase growth and profitability. Detailed information on the business performance and the outlook will be published in the 2024 Annual Report on March 7, 2025.
|
Contact Investor Relations |
|
Markus Abderhalden, CFO Phone +41 71 757 54 80 Mobile +41 79 436 26 22 |
Sign up for email updates from COLTENE Holding AG at invest.coltene.com .
|
Financial Calendar |
|
|
Release of Annual Report 2024 and Media and analyst conference on the 2024 financial year |
7 March 2025 |
|
Annual General Meeting 2025 |
23 April 2025 |
|
Release Half-Year Report 2025 and Media and analyst conference on the 2025 half-year results |
8 August 2025 |
About COLTENE
COLTENE is an international developer, manufacturer, and seller of dental consumables and small equipment in the areas of Infection Control, Dental Improvement, and Treatment Auxiliaries. COLTENE has state-of-the-art production facilities in the USA, Canada, Germany, France, Hungary and Switzerland as well as own sales organizations in all major markets including Europe, North and Latin America, Japan, China, and India. Dentists, DSOs, dental clinics, and dental labs all around the globe trust COLTENE's high-quality products. The registered shares of COLTENE Holding AG (CLTN) are listed on SIX Swiss Exchange. Learn more about COLTENE and our products at www.coltene.com .
This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial conditions. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.